Uri Weinberg, Chief Science Officer at NovoCure Ltd (NVCR), sold 8,143 shares at $120.00 ($946K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $946k NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.00 | 2,617 | $283K | 29.9% |
| 2 | $120.00 | 1,201 | $144K | 15.2% |
| 3 | $120.00 | 1,946 | $234K | 24.7% |
| 4 | $120.00 | 2,379 | $285K | 30.2% |
| Total | $116.14 avg | 8,143 | $946K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $168K | — | Filing → |
| NVCR | SELL | 2021-05-12 | $2.1M | — | Filing → |